Background Image
Table of Contents Table of Contents
Previous Page  200 / 658 Next Page
Information
Show Menu
Previous Page 200 / 658 Next Page
Page Background

6

The Utilization of Novel Platform in a LC-MS/MS Work ow for the Analysis of Vitamin D, Testosterone, Immunosuppressants, Chemotherapeutics and Cortisol

Conclusion

A large number of compounds, with logP values ranging from -1 to 5, have been validated on

a new LC/MS/MS platform demonstrating the viability of the Prelude SPLC System for

compounds of interest to clinical researchers..

The Prelude SPLC Systemʼs lower void volume results in sample run times that are 20-30%

shorter. The reduced run time results in reduced cost due to lower consumption of mobile

phases and less waste disposal.

The Prelude SPLC uses a single syringe fill per sample, which removes the need for pulse

dampeners, reduces the mechanical wear and tear on pump parts such as pump seal and

active check valves, and does not need proportioning valves. The result is far less required

maintenance, reducing operating cost and down time.

OQ for Each Compound

1.0

1.5

2.0

2.5

3.0

Cortisol

Time (min)

1.0

1.5

2.0

2.5

3.0

Methotrexate

Time (min)

1.0

1.5

2.0

2.5

3.0

25-Hydroxy Vitamin D3

Time (min)

1.0

1.5

2.0

2.5

3.0

Sirolimus

Time (min)

1.0

1.5

2.0

2.5

3.0

Everolimus

Time (min)

specificity criterion. Recoveries, including matrix effects, were all around 90% or higher. All the

data is summarized in Tables 1 to 3. Figure 1 depicts representative standard curves for each

compound tested. Representative chromatograms at the lower limit of quantitation (LLOQ) for

each compound are shown in Figure 2.

The improvement in run times resulting from the lower void volumes of the Prelude SPLC

System verses a conventional HPLC is illustrated in Figure 3 for vitamin D. The same mobile

phases and columns were used for the comparison. When using on-line clean-up the duration

of certain steps cannot be changed because they are dependent on the chromatographic

separation needed. The duration of others steps in the process are related to how long it takes

for solvent changes to reach the column. The sample clean-up and sample elution steps are

dependent on the chromatography and; therefore, the time for those steps remain the same.

However, the transfer, column cleaning and re-equilibration steps can be reduced. On a

conventional HPLC the transfer step was 75 sec vs. 60 seconds on the Prelude SPLC. The

column clean-up and equilibration steps were reduced from 150 to 60 seconds. The result is a

reduction in run time of 29% (5:15 minutes to 3:45 minutes). A shorter run time also reduced

solvent consumption by 33%.

FIGURE 3. Comparison of the Method Run Time for Vitamin D on a Prelude

SLPC LC/MS/MS System to that of a Conventional HPLC System

0

50

100

150

200

250

300

350

Prelude SPLC

Conventional HPLC

Sample

Clean-up

Sample

Clean-up

Sample

Transfer

Sample

Transfer

Sample Elution

Sample Elution

Column

Clean-up

Column

Clean-up

Equilbration

Equilbration

Time (sec)

1.0

1.5

2.0

2.5

3.0

Docetaxel

Time (min)